FDA Officials OK Generic Overactive Bladder Treatment

Camber recently announced the FDA approval of Tolterodine Tartrate ER capsules, a generic version of Detrol LA (tolterodine, Pharmacia & Upjohn).¹

The capsules, available in 2mg and 4mg doses, are used to treat overactive bladder, a disorder of the bladder that causes the sudden urge to urinate. Overactive bladder can lead to the involuntary loss of urine, otherwise known as incontinence, according to a press release from Camber.¹

Other common symptoms of overactive bladder include difficulty controlling one’s urination, urinating more frequently than 8 times in 24 hours, and waking up at least 2 times per night to urinate, according to the Mayo Clinic. Risk factors for overactive bladder include having an enlarged prostate, being diabetic, or cognitive decline. Treatment with tolterodine tartrate ER capsules may be used in combination with fluid schedules, timed voiding, techniques to strengthen the pelvic floor.²

Having the constant urge to urinate, or inability to hold urine in the bladder, can be embarrassing and disrupt one’s daily work or social life if untreated.² Official with Camber said the company recognizes the need for access to generic medicine, such as tolterodine tartrate, and has committed to bringing high quality generics to the market.¹

References

• Camber Pharmaceuticals Launches Generic Detrol LA® [news release]. Piscataway, New Jersey; February 13, 2019: Camber Pharmaceuticals. [email] Accessed Feb 14, 2019.
• Overactive Bladder Symtpoms and Causes Overview. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/overactive-bladder/symptoms-causes/syc-20355715. Accessed Feb 14, 2019.